Methods for modifying DNA and for detecting effects of such modification
on interaction of encoded modified polypeptides with target substrates
    1.
    发明授权
    Methods for modifying DNA and for detecting effects of such modification on interaction of encoded modified polypeptides with target substrates 失效
    用于修饰DNA和用于检测这种修饰对编码的修饰多肽与靶基质相互作用的方法

    公开(公告)号:US5677153A

    公开(公告)日:1997-10-14

    申请号:US346333

    申请日:1994-11-29

    CPC classification number: C12N15/102

    Abstract: The invention relates to methods and mutation linkers to modify DNA, to methods for producing libraries containing a multiplicity of modified DNA, and to methods for using such libraries for screening modified proteins encoded by such DNA. The DNA targeted for modification typically encodes a polypeptide such as an enzyme. The libraries are used to determine the effect of such modification or the interaction of the modified polypeptides with a target. In preferred embodiments, the invention relates to methods for making and using libraries containing DNA encoding modified antibiotic hydrolases to screen antibiotics against one or more of the modified antibiotic hydrolases produced by such libraries. Susceptibility or lack of susceptibility of an antibiotic to neutralization provides an indication of whether wild-type antibiotic hydrolases are likely to mutate to confer resistance to the antibiotic.

    Abstract translation: 本发明涉及用于修饰DNA的方法和突变接头,用于产生含有多个修饰的DNA的文库的方法,以及使用这种文库筛选由此DNA编码的修饰蛋白的方法。 靶向修饰的DNA通常编码多肽,例如酶。 文库用于确定这种修饰的作用或修饰的多肽与靶标的相互作用。 在优选的实施方案中,本发明涉及制备和使用含有编码经修饰的抗生素水解酶的DNA的文库的方法,以筛选针对一种或多种由这些文库产生的经修饰的抗生素水解酶的抗生素。 敏感性或抗生素对中和的敏感性不足提供了野生型抗生素水解酶是否可能发生变异以赋予抗生素抗性的指征。

    SMALL MOLECULE COMPOUNDS AS BROAD-SPECTRUM INHIBITORS OF METALLO-BETA-LACTAMASES
    2.
    发明申请
    SMALL MOLECULE COMPOUNDS AS BROAD-SPECTRUM INHIBITORS OF METALLO-BETA-LACTAMASES 审中-公开
    小分子化合物作为METALLO-BETA-LACTAMASES的广谱光谱抑制剂

    公开(公告)号:US20120329842A1

    公开(公告)日:2012-12-27

    申请号:US13332793

    申请日:2011-12-21

    CPC classification number: A61K31/425

    Abstract: The present invention concerns methods and/or compositions for treatment and/or prevention of bacterial infection wherein the bacteria has at least one metallo-β-lactamase. The bacteria are provided with an inhibitor of the metallo-β-lactamase, for example in conjunction with an antibiotic that targets the bacteria. The bacteria may be a drug-resistant strain or susceptible to becoming a drug-resistant strain. In specific embodiments, the bacteria is Pseudomonas or Acinetobacter spp.

    Abstract translation: 本发明涉及用于治疗和/或预防细菌感染的方法和/或组合物,其中细菌具有至少一种金属 - β-内酰胺酶。 细菌具有金属 - β-内酰胺酶的抑制剂,例如与针对细菌的抗生素结合。 细菌可能是耐药菌株或易成为耐药菌株。 在具体实施方案中,细菌是假单胞菌属或不动杆菌属。

    PEPTIDE DENDRIMERS: AFFINITY REAGENTS FOR BINDING NOROVIRUSES
    3.
    发明申请
    PEPTIDE DENDRIMERS: AFFINITY REAGENTS FOR BINDING NOROVIRUSES 审中-公开
    肽衍生物:用于结合非肠毒素的亲和试剂

    公开(公告)号:US20110020786A1

    公开(公告)日:2011-01-27

    申请号:US12681835

    申请日:2008-10-07

    CPC classification number: A61K38/10 C07K7/08 G01N33/56983 G01N2333/08

    Abstract: Noroviruses are recognized as the most common cause of outbreaks of acute gastroenteritis in humans. Therefore, the present invention relates to peptides or dendrimers that bind Noroviruses and the methods for identifying and synthesizing these peptides. It also relates to the detection of Noroviruses using said peptides or dendrimers formed by them.

    Abstract translation: 诺维病毒被认为是人类急性胃肠炎爆发的最常见原因。 因此,本发明涉及结合诺如病毒的肽或树状大分子以及鉴定和合成这些肽的方法。 它还涉及使用由它们形成的所述肽或树枝状大分子的诺如病毒的检测。

    Peptide inhibitors of beta lactamases
    4.
    发明申请
    Peptide inhibitors of beta lactamases 审中-公开
    β-内酰胺酶的肽抑制剂

    公开(公告)号:US20050186197A1

    公开(公告)日:2005-08-25

    申请号:US11059226

    申请日:2005-02-16

    CPC classification number: C07K7/06

    Abstract: Peptide inhibitors of β-lactamases have been identified by the synthesis of peptide arrays using synthesis SPOT technology. These peptide inhibitors of β-lactamase have activity against a broad spectrum of β-lactamases and are useful in a variety of applications.

    Abstract translation: 已经通过使用合成SPOT技术合成肽阵列来鉴定β-内酰胺酶的肽抑制剂。 β-内酰胺酶的这些肽抑制剂具有抗广泛β-内酰胺酶的活性,并且可用于各种应用。

Patent Agency Ranking